Quantcast

Latest Metered-dose inhaler Stories

2011-02-09 08:00:00

MIDLOTHIAN, Va., Feb. 9, 2011 /PRNewswire/ -- Today, PARI Respiratory Equipment launched an updated company website at www.pari.com. In addition to providing visitors with a beautiful new interface, the website includes easy access to: Continuing Education classes Product instructional videos Frequently asked questions and answers for patients Product instructions for use Information on how to access and differentiate between various types of nebulizers, compressors, holding chambers,...

2010-12-01 07:00:00

REDWOOD CITY, Calif., Dec. 1, 2010 /PRNewswire/ -- Pearl Therapeutics Inc. today announced that their lead combination bronchodilator, PT003, met the primary efficacy endpoint in a recently completed Phase 2b clinical trial in patients with moderate to very severe chronic obstructive pulmonary disease (COPD). These top-line results show that PT003 provides superior bronchodilation compared to the current market leader, tiotropium bromide (Spiriva®...

2010-10-19 08:00:00

REDWOOD CITY, Calif., Oct. 19 /PRNewswire/ -- Pearl Therapeutics Inc., a privately held company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), today announced a $69 million Series C financing. The financing round was led by Vatera Healthcare Partners and included existing investors, Clarus Ventures, New Leaf Venture Partners and 5AM Ventures. With this...

2010-10-19 07:18:00

HORSHAM, Pa., Oct. 19 /PRNewswire/ -- Teva Respiratory announced today the launch of EIB Active, a national health campaign to raise awareness about exercise-induced bronchospasm, or EIB, a condition that impacts an estimated 30 million people in the United States. EIB is a treatable condition that causes wheezing, coughing and chest tightness during or immediately following exercise or physical activity. Despite the large number of people living with EIB, diagnosis remains low due to a...

2010-09-14 09:07:00

LOURES, Portugal, September 14, 2010 /PRNewswire/ -- Hovione is announcing the approval in Japan of Inavir(R), Dry Powder Inhaler 20mg, for treatment of influenza. This approval has been granted to Daiichi Sankyo Company Ltd, a licensee of Hovione for the TwinCaps(R) inhaler which delivers the drug to the lungs. Hovione developed the TwinCaps(R) inhaler specifically for this indication. Inavir(R) directly delivers the drug to the infected airways of influenza patients, and a single...

2010-09-08 07:19:00

HORSHAM, Pa., Sept. 8 /PRNewswire/ -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced the publication of results from a real-life observational study of the General Practice Research Database (GPRD), which revealed that asthma patients treated with QVAR® (beclomethasone dipropionate HFA), either as initial therapy or with an increase (step up) in dose, had a similar or better chance of achieving asthma control as patients who were treated with...

2010-05-18 08:15:00

REDWOOD CITY, Calif., May 18 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, presented results from four studies that provide support for further development of PT003, the company's fixed dose combination of glycopyrrolate and formoterol delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA-MDI). The data were presented in a...

2010-05-17 08:00:00

REDWOOD CITY, Calif., May 17 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, has been named a TiE50 Winner in the BioSciences category, as a leader in innovation, ingenuity and management excellence. The award was presented to Pearl during TiEcon 2010, an annual convention hosted by The Indus Entrepreneurs (TiE), an organization dedicated to...

2010-05-05 07:00:00

REDWOOD CITY, Calif., May 5 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced four upcoming poster presentations at the Annual Meeting of the American Thoracic Society (ATS) to be held at the Ernest N. Morial Convention Center in New Orleans from May 14-19, 2010. Results from Pearl's Phase 1 safety and pharmacokinetics study of...

2010-04-15 08:30:00

ST. PAUL, Minn., April 15 /PRNewswire-Asia/ -- 3M Drug Delivery Systems recently advanced its participation in the Asian market with a sponsorship of the Asia Pharma R&D Leaders 2010 event, held March 4 and 5 in Shanghai, China. The event, organized by Global Leaders Institute, the leading life science event producer in China, brings together leading pharmaceutical industry professionals, policymakers, and academics to discuss Asia's role in the manufacturing, research and development...


Latest Metered-dose inhaler Reference Libraries

Nicotine Replacement Therapy
2013-03-04 16:06:28

Nicotine replacement therapy is the administration of nicotine by other means than smoking. This change in the way nicotine is delivered prevents the harmful effects of smoking and is usually used in smoking cessation. Types Nicotine replacement therapy can be administered in several forms. The type used depends on the patient and what fits into their lifestyle best. The forms available include: Nicotine patches – transdermal (through the skin) Nicotine gum – orally (through the...

More Articles (1 articles) »
Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related